The Standard – April 2019

Siloxanes are a class of chemicals recognized by their Si-O-Si linkages and encompass both linear and cyclic compounds. The cyclic methylsiloxanes have been heavily used in cosmetics and cleaning products for their emollient and hydrophobic properties. 

Since July 2018 numerous batches of heart medications contaminated with known probable carcinogenic compounds have been reported. The initial recall of the blood pressure medicine Valsartan has since expanded to also include the medicines Losartan and Irbesartan. The cause for concern and ultimately for recalling these medicines stems from the detection of known probable carcinogens N-Nitrosodimethylamine (NDMA) and N-Nitrosodiethylamine (NDEA). Recently, the related compound, N-Nitroso-N-methyl-4-aminobutryic acid (NMBA), was also detected in Losartan and Irbesartan, sparking new recalls of those medicines. More information regarding the recall timeline and status can be found on the US FDA’s website, as accessed here.

The environmental group at CIL has recently undergone some very exciting changes and growth. As noted in our previous newsletter, CIL recently hired Hervé Mohr as our new EMEA Sales Manager for Environmental Standards. In addition, due to the tremendous growth of our product lines we have recently hired Jess Keber as our new Account Coordinator and promoted Kayla Meehan to Inside Sales.